• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[局部因素在复发性丹毒中的重要性]

[The importance of local factors in recurrent erysipelas].

作者信息

Stöberl C

出版信息

Z Hautkr. 1985 May 1;60(9):712, 715-8, 721-3.

PMID:4013460
Abstract

We report on 366 patients suffering from erysipelas who have been treated in 1977 to 1981. 263 of them had primary infections, 103 showed relapsing erysipelas. In the course of treatment, sex, age, localisation, as well as local terrain factors have been evaluated. Therapy consisted of high dosage antibiotic treatment and correction of the local predisposing terrain factors. 41 of the 103 patients with relapsing erysipelas have been controlled during an observation period between 2 and 6 years. 27 patients of these 41 (63.9%) did not suffer a relapse within the observation period, 14 (34.1%) reported relapses. Local predisposing factors were found more frequently in patients with recurrence of the disease. Therefore, strict therapeutic control of terrain factors seems to be much more important than long-term antibiotic treatment.

摘要

我们报告了1977年至1981年期间接受治疗的366例丹毒患者。其中263例为原发性感染,103例表现为复发性丹毒。在治疗过程中,对患者的性别、年龄、感染部位以及局部地形因素进行了评估。治疗包括高剂量抗生素治疗和纠正局部诱发地形因素。103例复发性丹毒患者中有41例在2至6年的观察期内病情得到控制。这41例患者中有27例(63.9%)在观察期内未复发,14例(34.1%)报告复发。在疾病复发的患者中,局部诱发因素更为常见。因此,严格治疗控制地形因素似乎比长期抗生素治疗更为重要。

相似文献

1
[The importance of local factors in recurrent erysipelas].[局部因素在复发性丹毒中的重要性]
Z Hautkr. 1985 May 1;60(9):712, 715-8, 721-3.
2
[Treatment of chronic recurrent erysipelas with streptococcal vaccine].[用链球菌疫苗治疗慢性复发性丹毒]
Hautarzt. 1989 Apr;40(4):215-21.
3
[Combined penicillin-streptococcal vaccine treatment of chronically recurring erysipelas].[青霉素-链球菌联合疫苗治疗慢性复发性丹毒]
Dermatol Monatsschr. 1975 Nov;161(11):936-42.
4
Sodium selenite as prophylaxis against erysipelas in secondary lymphedema.亚硒酸钠用于预防继发性淋巴水肿中的丹毒。
Anticancer Res. 1998 May-Jun;18(3C):2227-30.
5
[Secondary lymphedema: a therapeutic challenge].[继发性淋巴水肿:一项治疗挑战]
Hautarzt. 2006 Apr;57(4):333-5. doi: 10.1007/s00105-006-1118-7.
6
Erysipelas of the upper extremity following locoregional therapy for breast cancer.乳腺癌局部区域治疗后上肢丹毒
Breast. 2005 Oct;14(5):347-51. doi: 10.1016/j.breast.2005.02.011. Epub 2005 Jun 28.
7
[Primary and secondary prevention for erysipelas].[丹毒的一级和二级预防]
Ann Dermatol Venereol. 2001 Mar;128(3 Pt 2):368-75.
8
[Erysipelas after breast cancer treatment].[乳腺癌治疗后的丹毒]
Tunis Med. 2002 Aug;80(8):465-8.
9
Epidemiology and comorbidity of erysipelas in primary care.基层医疗中丹毒的流行病学与共病情况
Dermatology. 2007;215(2):118-22. doi: 10.1159/000104262.
10
[Histologic studies on the skin of patients with recurrent erysipelas].[复发性丹毒患者皮肤的组织学研究]
Dermatol Monatsschr. 1972 Mar;158(3):173-80.

引用本文的文献

1
Recurrent cellulitis: risk factors, etiology, pathogenesis and treatment.复发性蜂窝织炎:危险因素、病因、发病机制与治疗。
Curr Infect Dis Rep. 2014 Sep;16(9):422. doi: 10.1007/s11908-014-0422-0.
2
Antibiotic prophylaxis in recurrent erysipelas.复发性丹毒的抗生素预防
Infection. 1993 Nov-Dec;21(6):390-3. doi: 10.1007/BF01728920.